Pennsylvania Pharmacists Association Educational Foundation. Pharmacists Advancing Patient Care 2016 Grant Application

Size: px
Start display at page:

Download "Pennsylvania Pharmacists Association Educational Foundation. Pharmacists Advancing Patient Care 2016 Grant Application"

Transcription

1 Pennsylvania Pharmacists Association Educational Foundation 508 North Third Street, Harrisburg, PA Phone: Fax: Pharmacists Advancing Patient Care 2016 Grant Application It is recommended that you save this form to your computer and then type your information directly into the form. Handwritten applications will not be accepted. Please note there is an optional pre-submission recorded webinar with general information and application instructions on the PPA website under Foundation and Grant Program. For 2016: The PPA Educational Foundation encourages the submission of grants that investigate, demonstrate, document, measure or otherwise explore the value of pharmacist involvement in the Patient Centered Medical Home (PCMH), Accountable Care Organizations(ACOs) or other innovative models of collaboration. Of particular interest to the Foundation, are the following aspects related to the business model of embedding a pharmacist in the PCMH/ACO: productivity, ROI, payment, and/or quality outcomes/measures. This focus does not preclude applications of another topic or project. Title of Project: The Pharmacist s Perception of Electronic Cigarettes Total Amount requested (Maximum is $1,000): $1000 (Be sure to see the information on your submitted budget and what may be included) PRIMARY APPLICANT - PERSONAL PROFILE Name (include designations): Alana Grabigel, PharmD Candidate 2016 Current PPA member: *Membership as a PPA Member is required Applicants may reside in another state, but your primary practice location must be in Pennsylvania. Years in Practice: 4 (Pharmacy school PY4 student); Excepted graduation May 2016 Current Position: Student Pharmacist Years at Current Site: 4 years 1 PPA Educational Foundation Grant Application

2 Name of Practice: Duquesne University Mylan School of Pharmacy Pharmacy Practice Telephone: Cell phone: Preferred Address: Preferred Mailing Address: Work: Home: Home Address: 120 S. 12 th Street City: Pittsburgh State: PA Zip Code: Work Address: 316 Bayer Learning Center, 600 Forbes Ave City: Pittsburgh State: PA Zip Code: Pharmacy Practice Web site: Co-applicants/investigator(s): (Please list names and s) Lauren E. Wolfe, Pharm.D.; and Jamie L. McConaha, PharmD, CGP, BCACP; Note: Students and Pharmacy Technicians must have a faculty or pharmacist member also complete this cover application including signature. Students should use their school as the practice site and years at practice site as years in pharmacy school, noting intended graduation date. PPA Educational Foundation Board of Directors may not be grant applicants or coapplicants/co-investigators PRACTICE PROFILE Type of practice setting: Independent: Clinic: Managed Care: Home Health Care: Chain (4 or more pharmacies under same ownership): Hospital Outpatient: Consultant: Other: Click here to enter text. Number of Pharmacists: Three Number of Pharmacy Technicians: Five Average Prescription: (volume/week)(if applicable) : ~1,500 prescriptions/week 2 PPA Educational Foundation Grant Application

3 Describe the population your practice serves: My current practice site serves a working class population. List any special or unique clinical services currently offered at your practice: My practice site has programs in place to help encourage compliance to maintenance medications. First-fill counseling points are also provided. PROJECT PROPOSAL Please attach a typed description outlining, in detail, your proposal regarding your proposed innovative patient care service. Your description must address each of the following areas limiting your response to 4 pages. The four page limit does not include the attachment outlined in the final bullet point or this cover application. General project description (please include how you believe this will advance the practice of pharmacy) Project objectives and evaluation strategy Methods to be utilized Timetable for the project Budget Include total project budget outlining specific funds being requested for this grant.* Attachments: Supporting documents (not included in the 4 page limit) These would include samples of any assessment tool(s, survey(s), or patient materials you plan to utilize If these are not fully developed include basic structure and plan. Note: Applications that request funds for capital/equipment items, medication purchases, or for administrative related expenses such as salaries or travel expenses will not be considered. In order to be sure we receive your full application, please provide the following information: Total descriptive pages in addition to this application form: Six List each of the additional attachments: Appendix A: Pharmacist Survey If this is a student or pharmacy technician application be sure to include the additional cover application for the pharmacist co-applicant and check here: 3 PPA Educational Foundation Grant Application

4 SIGNATURE The information I have provided in support of this application is complete and correct to the best of my knowledge. I have read the accompanying Grant Announcement and am aware of all requirements for participation. If selected to receive a PPA Educational Foundation Grant, I agree to provide the Foundation with a final report and to permit publication of these reports in related publications. Payment of the final half of the grant is contingent upon receipt of the report. Please insert an electronic signature file or print, sign, scan, and send. If this is not feasible, print your name below, for inclusion on the electronic submission and then print a copy of this last page, actually sign and fax just this last page to Alana Grabigel October 31, 2015 Signature Date Deadline: November 1, 2015 This application is to be ed to: PPA Educational Foundation foundation@papharmacists.com Please learn more about the PPA Educational Foundation and the work we are doing at Upon receipt of your application, a confirmation receipt will be sent to you by . It is your responsibility as the applicant to verify such receipt. If you do not receive a confirmation of receipt within 72 hours, it is your obligation to follow-up to assure there was not an issue and that your application was, in fact, received. 4 PPA Educational Foundation Grant Application

5 THE PHARMACIST S PERCEPTION OF ELECTRONIC CIGARETTES Project Proposal for PPA Educational Foundation Grant 2016 Background/General Project Description Electronic cigarettes, also known as e-cigarettes, are a type of electronic nicotine delivery system that has been increasing in popularity among adults and adolescents in recent years. In 2007, e-cigarettes were introduced to the US market without FDA regulation. While manufacturers of e-cigarettes may advertise their product as a form of smoking cessation, there is insufficient evidence to support this claim. The long-term outcomes of e-cigarettes remain unknown, and little data exists concerning associated adverse effects. It is important that pharmacists and other healthcare professionals be mindful of the practice of e-cigarette use and provide the appropriate education to their patients. While the number of conventional cigarette smokers in the US continues to decrease, it appears that the opposite is true with e-cigarette users. Since 2010, there has been an increase in the use of e-cigarettes, which has corresponded with an increase in the product s marketing. Although representative national data is limited, surveys show that from 2010 through 2013, the number of first-time users of e-cigarettes increased from 3.3% to 8.5% in adults. 1 In the adolescent population, similar trends have also been seen. From 2011 to 2014, the use of e- cigarettes increased from 1.5% to13.4% in high school students and from 0.6% to 3.9% in middle school students. 2,3 Among cancer patients, a study indicated that rates of use have increased from 10.6% (2012) to 38.5% (2013). 4 Most adult and adolescent users of e-cigarettes concurrently smoke conventional cigarettes. During 2013, 76.8% of the people who had recently tried e-cigarettes also were smokers of conventional cigarettes. 5 Adults have also reported using e-cigarettes as a cessation tool and as a safer alternative to traditional cigarettes. Data has shown conflicting results when evaluating the use of e-cigarettes as a cessation device. A recent longitudinal study reported that daily users of e-cigarettes were 6 times as likely as non-users to report quitting. 6 In contrast, a study conducted on cancer patients who were enrolled in a tobacco cessation program indicated that patients who used e-cigarettes were twice as likely to be smoking at follow-up as compared with their counterparts that did not use e-cigarettes. 7 Another reported finding of a study supported the premise that e-cigarette users were also more nicotine dependent. 1 The FDA and the American Lung Association support the use of the seven approved therapies in combination with counseling as the most effective way to help patients achieve smoking cessation. These associations do not support the use of e-cigarettes. 8 Pharmacist involvement is vital to successful smoking cessation and treatment of tobacco use. Pharmacists are accessible in all fields of practice to educate patients on the long-term risks of smoking and to encourage them to initiate the process that will lead them to a smoke-free life. 5 PPA Educational Foundation Grant Application

6 Pharmacists can help patients develop cessation plans and provide recommendations for lifestyle changes and pharmacologic therapies. Due to the increasing popularity of e-cigarettes, pharmacists will be called upon to serve as an informational resource for patients seeking advice on the product as well as a care provider for patients who use them. However, due to the lack of FDA regulation and the scarcity of clinical data, many pharmacists may be under-informed on e- cigarettes and their associated risks of use. An assessment of pharmacists perceptions of e-cigarettes supports the advancement of pharmacy practice by identifying gaps that may exist in product awareness, popularity of use and risks to patient health. This proactive assessment highlights the upward trend in e-cigarette use, and enhances patient care by presenting the topic in a forum that provides pharmacists the opportunity to become more familiar with the products when counseling patients. This survey promotes a better understanding of current opinions among pharmacists on e-cigarette products and provides consensus on whether further steps should be taken to increase product training and information dissemination. Study Objectives and Evaluation Strategy The objective of this study is to evaluate pharmacists perception and knowledge of e- cigarettes. Study benefits aim to also include an increase in recipient awareness of topic, as well as support for future FDA regulation of the product. The study objectives seek to assess pharmacists knowledge of e-cigarette products (including perceived safety and place in therapy as a smoking cessation aid), pharmacists level of comfort with counseling patients on e- cigarettes, and pharmacists collection of e-cigarette usage as a marker of tobacco status. Obtainment of the research objectives will be met through assessment of the following research questions: 1. Are pharmacists knowledgeable about e-cigarettes? 2. Are pharmacists observant of the increasing prevalence of e-cigarettes and the marketing tactics that target adolescents? 3. Are pharmacists aware of the lack of regulatory parameters associated with e- cigarette composition and manufacturing? 4. At what rate do pharmacists encounter patients that use e-cigarettes? 5. Do pharmacists ask about e-cigarette use when assessing a patient s smoking status, and if so, how do they quantify e-cigarette usage? 6. Are pharmacists aware of the adverse physiological effects associated with e- cigarette use? 7. Do pharmacists believe that e-cigarettes may be used as a cessation tool? 6 PPA Educational Foundation Grant Application

7 Methods This study will utilize a survey methodology. Surveys will be mailed to 400 pharmacists who have an active Pennsylvania pharmacy license and practice in the community pharmacy setting. Surveys will be distributed evenly throughout Pennsylvania in order to achieve an adequate geographic representation. The surveys will be dispersed equally between male and female pharmacists. Pharmacists mailing addresses will be obtained by purchasing a valid mailing list. The survey will encompass a variety of questions assessing the pharmacist s familiarity with e-cigarettes and their prevalence in the patient care setting. Surveys will be distributed for a time period of 3 months, or until 100 surveys are completed. To help increase participation in this educational assessment, a small gift card incentive ($5.00) will be mailed to each participant who completes and returns the survey. This survey can be referenced in Appendix A. One of the objectives of the survey is to provide information to pharmacists on the prevalence and safety of e-cigarettes. In order to achieve this objective, we will ask that any participant who is interested in receiving additional information on the topic provide an address. An educational handout outlining relevant counseling points on e-cigarettes will be provided to further improve awareness. Information collected from pharmacist s survey response will be analyzed utilizing descriptive and inferential statistics, as appropriate. Outcomes from this study include knowledge of e-cigarettes, level of comfort with counseling patients on e-cigarettes, and opinion on the use of e-cigarettes as a cessation tool. Timeline Activity Projected Date Survey distribution to community pharmacists January 11, 2016 Data collection occurs January-March 2016 Data analysis and manuscript preparation April 2016 Manuscript submission May 2016 Presentation to the Pennsylvania Pharmacists February 2017 Association Budget Summary Line Item* Survey Postage (400 x $0.49) $ Return Postage (400 x $0.49) $ Incentive (100 x $5.00) $ Pharmacist Mailing List $50.00 Incentive Mailing Postage $58.00 Total $ *Please see budget details below for specific line items. Requested from Grant 7 PPA Educational Foundation Grant Application

8 Budget Details Mailing: The total of each mailing will cost 49 cents, assuming each item will weigh 1 oz. Therefore mailing to 400 pharmacists in Pennsylvania will total $196.00, plus an additional $ in order to provide return postage. A mailing list of pharmacists will also need to be purchased, which will cost an estimated $ Any remaining funds will be used for postage to mail incentives to survey participants. Incentive: We would like to provide an incentive to ensure adequate participation in our study. Assuming a generous 25% response rate, we will send $5.00 to 100 participants, totaling $ Incentives will be in the form of gift cards provided to each pharmacist who participates by responding to and returning the survey. References: 1. Orellana-barrios MA, Payne D, Mulkey Z, Nugent K. Electronic Cigarettes A Narrative Review for Clinicians. Am J Med. 2015;128 (7): Centers for Disease Control and Prevention (CDC). Notes from the field: electronic cigarette use among middle and high school students - United States, MMWR Morb Mortal Wkly Rep 2013; 62: Arrazola RA, Singh T, Corey CG, et al. Tobacco use among middle and high school students - United States, MMWR Morb Mortal Wkly Rep 2015; 64: Borderud SP, Li Y, Burkhalter JE, et al. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014; 120: Hajek P, Etter JF, Benowitz N, et al. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014; 109: Biener L, Hargraves JL. A longitudinal study of electronic cigarette use in a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2): Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014;120(22): E-cigarettes and Lung Health American Lung Association website. Updated March Accessed October 27, PPA Educational Foundation Grant Application

9 Appendix A: Pharmacist Survey Instructions: This survey is designed to collect information regarding the awareness of the use of electronic cigarettes. Please complete the following questions to the best of your knowledge. 1. Have you ever heard of electronic cigarettes, otherwise known as e-cigarettes, e-cigs, hookah pens, e-hookahs or vapor (vape) pipes? Yes No 2. How did you become aware of e-cigarettes? Internet/social media Friends/family/co-workers Patients Television/advertisement Other (please specify): 3. In the last five years, the reported use of e-cigarettes in adults and adolescents in the United States has? Increased Decreased Remained the same I don t know 4. Have you encountered patients that use e-cigarettes? Yes No 5. What is your confidence level on counseling a patient on e-cigarettes? Not confident at all Slightly confident Somewhat confident Fully Confident Do you believe that e-cigarettes can be used as a smoking cessation tool? Yes No I don t know 9 PPA Educational Foundation Grant Application

10 7. Are e-cigarettes addictive? Yes No I don t know 8. E-cigarettes are regulated by the FDA. True False 9. E-cigarettes are a safe alternative to conventional cigarettes. True False 10. Approximately how many different brands of e-cigarettes exist? > The amount of nicotine in e-liquid refills often is different from the amount listed on the package. True False 12. Which of the following are reported physiological effects of e-cigarette use? (Please check all that apply) Change in serum carbon monoxide level Increase in systolic blood pressure Increase in diastolic blood pressure Increase in heart rate Blood count changes (change in WBCs, lymphocytes, etc.) Decrease in exhaled nitric oxide Increase in respiratory impedances (a marker of airway flow resistance) Increase in airway resistance Your participation is greatly appreciated! If you would like to receive an electronic handout with counseling points on e-cigarettes, please provide an address below: 10 PPA Educational Foundation Grant Application

Use of electronic cigarettes (vapourisers) among adults in Great Britain

Use of electronic cigarettes (vapourisers) among adults in Great Britain May 2016 Use of electronic cigarettes (vapourisers) among adults in Great Britain 33 Summary of findings An estimated 2.8 million adults in Great Britain currently use electronic cigarettes (vape) up from

More information

PPA Educational Foundation Grant Report 2013 Kristin M. Franks

PPA Educational Foundation Grant Report 2013 Kristin M. Franks PPA Educational Foundation Grant Report 2013 Kristin M. Franks The impact of an Incentivized Employer-Driven, Pharmacist Run Know Your Numbers Clinic Kristin M. Franks, Pharm.D., Suzanne Higginbotham,

More information

INTRODUCTION. Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report - March 2011

INTRODUCTION. Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report - March 2011 TPCP Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report Report Prepared by Antionne Dewayne Alcorn, BS, CPC, CIT Contributors Miriam N Karanja, MBA Ma rc h 2 0 1 1 INTRODUCTION

More information

Stop Smoking. Key #2. It s Not Too Late to Benefit from Quitting! Health Benefits to Quitting. Other Reasons to Quit

Stop Smoking. Key #2. It s Not Too Late to Benefit from Quitting! Health Benefits to Quitting. Other Reasons to Quit Key #2 Stop Smoking There are many different poisons that can be found in cigarettes, such as carbon monoxide, tar, rat poison, paint thinner, and lighter fluid, just to name a few. Any of these toxins,

More information

TOBACCO CESSATION PILOT PROGRAM. Report to the Texas Legislature

TOBACCO CESSATION PILOT PROGRAM. Report to the Texas Legislature TOBACCO CESSATION PILOT PROGRAM Report to the Texas Legislature As Required by S.B. 10, 80 th Legislature, Regular Session, 2007 Texas Health and Human Services Commission September 2010 Table of Contents

More information

NICOTINE INHALING PRODUCTS AGE OF SALE RESTRICTIONS & PROXY PURCHASING GUIDANCE FOR PHARMACIES KEY POINTS

NICOTINE INHALING PRODUCTS AGE OF SALE RESTRICTIONS & PROXY PURCHASING GUIDANCE FOR PHARMACIES KEY POINTS NICOTINE INHALING PRODUCTS AGE OF SALE RESTRICTIONS & PROXY PURCHASING GUIDANCE FOR PHARMACIES KEY POINTS The following guidance has been prepared by the Department of Health in conjunction with the Medicines

More information

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS Executive Summary Chronic Obstructive Pulmonary Disease (COPD) is a common chronic

More information

Leveraging the Electronic Health Record (EHR) to Achieve Tobacco Systems Change

Leveraging the Electronic Health Record (EHR) to Achieve Tobacco Systems Change Leveraging the Electronic Health Record (EHR) to Achieve Tobacco Systems Change Case Study: Alaska Native Tribal Health Consortium (ANTHC) & Alaska Native Medical Center (ANMC) Tobacco Free Campus Policy

More information

PITFALLS IN E-CIGARETTE RESEARCH LESSONS FROM THE CURRENT LITERATURE

PITFALLS IN E-CIGARETTE RESEARCH LESSONS FROM THE CURRENT LITERATURE PITFALLS IN E-CIGARETTE RESEARCH LESSONS FROM THE CURRENT LITERATURE Dr Konstantinos Farsalinos Researcher Onassis Cardiac Surgery Center, Greece University of Patras, Greece COI 2 (unpublished yet) studies

More information

E-cigarettes: a new foundation for evidence-based policy and practice

E-cigarettes: a new foundation for evidence-based policy and practice E-cigarettes: a new foundation for evidence-based policy and practice Introduction Smoking rates in England are in long-term decline. However, tobacco use remains one of the country s major public health

More information

NIDA-AACAP Resident Training Award Application

NIDA-AACAP Resident Training Award Application NIDA-AACAP Resident Training Award Application NIDA-AACAP Resident Training Award in Substance Abuse and Addiction, supported by the National Institute on Drug Abuse The NIDA-AACAP Resident Training Award

More information

Journal of. Employee Assistance. The magazine of the Employee Assistance Professionals Association VOL. 36 NO. 2 2 ND QUARTER 2006

Journal of. Employee Assistance. The magazine of the Employee Assistance Professionals Association VOL. 36 NO. 2 2 ND QUARTER 2006 Employer Initiatives to Stop Smoking by Mary Hill, LCSW, CEAP As more employers take aggressive steps to reduce health care costs arising from employees tobacco use, EAPs can and must help ensure the process

More information

Internet and Mobile Phone Studies (E-epidemiology)

Internet and Mobile Phone Studies (E-epidemiology) Conducting studies on the Internet and mobile phones Jean-François ETTER, PhD Associate Professor IMSP, Faculty of Medicine, University of Geneva, Switzerland Jean-Francois.Etter@unige.ch HUG Colloque

More information

February 18, 2010. Dear Cessation Program Provider:

February 18, 2010. Dear Cessation Program Provider: February 18, 2010 Dear Cessation Program Provider: The Alabama Department of Public Health (ADPH) is pleased to present this Request for Application (RFA) for online cessation services for the Alabama

More information

2009 Mississippi Youth Tobacco Survey. Office of Health Data and Research Office of Tobacco Control Mississippi State Department of Health

2009 Mississippi Youth Tobacco Survey. Office of Health Data and Research Office of Tobacco Control Mississippi State Department of Health 9 Mississippi Youth Tobacco Survey Office of Health Data and Research Office of Tobacco Control Mississippi State Department of Health Acknowledgements... 1 Glossary... 2 Introduction... 3 Sample Design

More information

HOW TO STOP SMOKING. Dr Coral Gartner UQ Centre for Clinical Research

HOW TO STOP SMOKING. Dr Coral Gartner UQ Centre for Clinical Research HOW TO STOP SMOKING Dr Coral Gartner UQ Centre for Clinical Research ACKNOWLEDGEMENTS SOME TRUTHS There is no magic bullet Secret to successful quitting: keep trying make every quit attempt count Every

More information

Who will the policy apply to? Which staff members will be excluded from participating, if any?

Who will the policy apply to? Which staff members will be excluded from participating, if any? Worksheet for Implementing an Office System: Tobacco Use Cessation This worksheet will assist you in implementing an office system that ensures that, for every patient at every visit, tobacco use status

More information

Numerator Details. - An acute or nonacute inpatient admission with a diagnosis of AOD (AOD Dependence

Numerator Details. - An acute or nonacute inpatient admission with a diagnosis of AOD (AOD Dependence Description Measure 0004: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) (National Committee for Quality Assurance) The percentage of adolescent and adult patients with

More information

I choose to be smoke-free. A Workplace Guide for Employers

I choose to be smoke-free. A Workplace Guide for Employers I choose to be smoke-free. A Workplace Guide for Employers Committed to a Healthier Mississippi. Table of Contents Preface...1 Questions & Answers...2-3!...4-10 Sample Workplace Survey...11 The scientific

More information

Grant ID 044360 Page 4 Medical University of South Carolina Implementation of TelASK Quit Connection IVR System in Charleston Area Hospitals

Grant ID 044360 Page 4 Medical University of South Carolina Implementation of TelASK Quit Connection IVR System in Charleston Area Hospitals 1. Overall Aim & Objectives: The goal of this project is to implement an evidence-based Tobacco Cessation Management System in all hospitals in the Charleston, South Carolina region. The system should

More information

BMA calls for stronger regulation of e-cigarettes

BMA calls for stronger regulation of e-cigarettes BMA calls for stronger regulation of e-cigarettes March 2012 (updated January 2013) A briefing from the Board of Science and the Occupational Medicine Committee Summary A briefing from the BMA Occupational

More information

Teens and Tobacco in Minnesota, 2014 Update

Teens and Tobacco in Minnesota, 2014 Update Teens and Tobacco in Minnesota, 2014 Update Executive Summary Minnesota Department of Health Center for Health Equity Center for Health Statistics November, 2014 ii TEENS AND TOBACCO IN MINNESOTA, 2014

More information

Evaluating the impact of REMS on burden and patient access

Evaluating the impact of REMS on burden and patient access Evaluating the impact of REMS on burden and patient access Doris Auth, Pharm.D. Team Leader, Division of Risk Management Office of Medication Error Prevention and Risk Management Center for Drug Evaluation

More information

Country profile. Slovakia

Country profile. Slovakia WHO Report on the Global Tobacco Epidemic, 2013 Country profile Slovakia WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 19 December 2003 Date of ratification (or legal

More information

ISSUEBrief. Reducing the Burden of Smoking on Employee Health and Productivity. Center for Prevention

ISSUEBrief. Reducing the Burden of Smoking on Employee Health and Productivity. Center for Prevention Center for Prevention and Health ISSUEBrief Services Volume I, Number 5 Reducing the Burden of Smoking on Employee Health and Productivity This issue brief summarizes information presented during the fifth

More information

Adopting an Advanced Community Pharmacy Practice Experiential Educational Model Across Colleges of Pharmacy

Adopting an Advanced Community Pharmacy Practice Experiential Educational Model Across Colleges of Pharmacy Volume 2 Number 4 Article 56 2011 Adopting an Advanced Community Pharmacy Practice Experiential Educational Model Across Colleges of Pharmacy Jennifer L. Rodis Brandon T. Jennings Follow this and additional

More information

New Jersey Department of Health. Office of Tobacco Control, Nutrition and Fitness. Request for Applications (RFA)#2

New Jersey Department of Health. Office of Tobacco Control, Nutrition and Fitness. Request for Applications (RFA)#2 New Jersey Department of Health Office of Tobacco Control, Nutrition and Fitness Request for Applications (RFA)#2 Smoke-Free Housing / Worksite Wellness Smoke Free Housing/Worksite Wellness Grant The funding

More information

The Impact of Alcohol

The Impact of Alcohol Alcohol and Tobacco Smoking cigarettes and drinking alcohol are behaviors that often begin in adolescence. Although tobacco companies are prohibited from advertising, promoting, or marketing their products

More information

Company medical plan to include new option and Healthy for Life premium rate in 2016

Company medical plan to include new option and Healthy for Life premium rate in 2016 Company medical plan to include new option and Healthy for Life premium rate in 2016 Dear employees: We are all aware that health care costs and wellness are major issues throughout the country. Companies

More information

PREFERRED UNDERWRITING

PREFERRED UNDERWRITING PREFERRED UNDERWRITING For Solution 10 & Solution 20 Criteria Guide 2015 FOR ADVISOR USE ONLY Contents About this guide...1 Preferred underwriting...1 Availability...1 Risk classifications...1 Standard

More information

Main Section of the Proposal

Main Section of the Proposal Main Section of the Proposal 1. Overall Aim and Objectives: The primary aim of this proposed project is to increase the number of tobacco- using patients admitted to two University of Washington (UW) hospitals

More information

Improving smoking cessation in drug and alcohol treatment

Improving smoking cessation in drug and alcohol treatment Improving smoking cessation in drug and alcohol treatment Interim briefing on Turning Point s PHE-supported smoking cessation pilots Tobacco smoking is prevalent among drug and alcohol users, and contributes

More information

Medical Fitness. Annual Meeting December 2012. By: Deb Riggs, MEd, General Manager

Medical Fitness. Annual Meeting December 2012. By: Deb Riggs, MEd, General Manager Exercise is Medicine Referral Process Utilizing an EMR Medical Fitness Association Annual Meeting December 2012 By: Deb Riggs, MEd, General Manager Faculty Disclosure Deb Riggs Deb Riggs has listed no

More information

Country profile. Saudi Arabia

Country profile. Saudi Arabia WHO Report on the Global Tobacco Epidemic, 2015 Country profile Saudi Arabia WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 24 June 2004 Date of ratification (or legal

More information

How To Insure For Tobacco Dependence

How To Insure For Tobacco Dependence HEALTH INSURANCE COVERAGE FOR TOBACCO DEPENDENCE Survey of Managed Care Organizations in Texas Phyllis Gingiss, Dr.P.H. Melynda Boerm, M.Ed. March 2005 Prepared by the University of Houston Health Network

More information

Country profile. Sri Lanka

Country profile. Sri Lanka WHO Report on the Global Tobacco Epidemic, 2015 Country profile Sri Lanka WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 23 September 2003 Date of ratification (or legal

More information

Position Paper. Tobacco Prevention and Control in the California Community Colleges

Position Paper. Tobacco Prevention and Control in the California Community Colleges Position Paper Tobacco Prevention and Control in the California Community Colleges Written by: Beth Hoffman, RN, MSN Naomi Kitajima NP, MSN Kimberlee Homer Vagadori, MPH Adopted by HSACCC Executive Board

More information

RISK EVALUATION AND MITIGATION STRATEGY (REMS)

RISK EVALUATION AND MITIGATION STRATEGY (REMS) Initial REMS approval: 08/2015 NDA 22526 Addyi TM (flibanserin) Serotonin 1A receptor agonist and a Serotonin 2A receptor antagonist Sprout Pharmaceuticals, Inc. 4208 Six Forks Road, Suite 1010 Raleigh,

More information

UW-Center for Tobacco Research and Intervention (CTRI) Report Coverage of Tobacco Cessation Treatments, Wisconsin 2004

UW-Center for Tobacco Research and Intervention (CTRI) Report Coverage of Tobacco Cessation Treatments, Wisconsin 2004 UW-Center for Tobacco Research and Intervention (CTRI) Report Coverage of Tobacco Cessation Treatments, Wisconsin 2004 Report Summary This is the second survey of Wisconsin health plans assessing coverage

More information

How to use the Brief Tobacco Cessation Intervention Form

How to use the Brief Tobacco Cessation Intervention Form How to use the Brief Tobacco Cessation Intervention Form The following information is related to the use of an office brief tobacco use cessation intervention using a check off form to obtain a patients

More information

Tanzania. Report card on the WHO Framework Convention on Tobacco Control. 29 July 2007. Contents. Introduction

Tanzania. Report card on the WHO Framework Convention on Tobacco Control. 29 July 2007. Contents. Introduction Report card on the WHO Framework Convention on Tobacco Control Tanzania Introduction Tobacco use is the single most preventable cause of death in the world today, and is estimated to kill more than five

More information

Nova Scotia Tobacco Control Strategy Evaluation: Preliminary Results

Nova Scotia Tobacco Control Strategy Evaluation: Preliminary Results Nova Scotia Tobacco Control Strategy Evaluation: Preliminary Results 1 Evaluation Objectives To describe the implementation to date of each component of the Strategy To assess the outcomes of the Strategy

More information

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING University of Massachusetts Medical School MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING Course Description Goals and Learning Objectives 1 2012 55 Lake Avenue North, Worcester, MA 01655 www.umassmed.edu/tobacco

More information

HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY Simsbury, Connecticut 06089 Section 1

HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY Simsbury, Connecticut 06089 Section 1 GROUP LIFE INSURANCE APPLICATION HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY Simsbury, Connecticut 06089 Section 1 Policyholder: American College of Emergency Physicians Policy No.: AGL-1905 Certificate

More information

Democratic People's Republic of Korea

Democratic People's Republic of Korea WHO Report on the Global Tobacco Epidemic, 2015 Country profile Democratic People's Republic of Korea WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 17 June 2003 Date of

More information

Transitioning to Express Scripts

Transitioning to Express Scripts Transitioning to Express Scripts Welcome to Express Scripts. We re pleased to announce that, beginning 1/1/2015 the City of Frisco prescription benefit will be managed by Express Scripts. Express Scripts

More information

THINGS YOU SHOULD KNOW ABOUT. quitting smoking

THINGS YOU SHOULD KNOW ABOUT. quitting smoking THINGS YOU SHOULD KNOW ABOUT quitting smoking Smoking learn how you can quit* You may be 1 of the 46 million Americans who smoke cigarettes. You may have tried to quit before, or you may want to quit.

More information

SMOKING CESSATION. Presented by your Cigna Employee Assistance Program (EAP)

SMOKING CESSATION. Presented by your Cigna Employee Assistance Program (EAP) SMOKING CESSATION Presented by your Cigna Employee Assistance Program (EAP) SEMINAR GOALS Understand your tobacco use habit Learn health consequences of smoking and tobacco use Become familiar with smoking

More information

Questions and Answers About Smoking Cessation

Questions and Answers About Smoking Cessation Questions and Answers About Smoking Cessation 1. How important is it to stop smoking? It is very important. Tobacco use remains the single most preventable cause of death in the United States. Cigarette

More information

Country profile. Austria

Country profile. Austria WHO Report on the Global Tobacco Epidemic, 2015 Country profile Austria WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 28 August 2003 Date of ratification (or legal equivalent)

More information

11.1 General quit lines North American Quitline Consortium (NAQC) Web site: http://www.naquitline.org

11.1 General quit lines North American Quitline Consortium (NAQC) Web site: http://www.naquitline.org 11.Resources 11.1 General quit lines North American Quitline Consortium (NAQC) Web site: http://www.naquitline.org The NAQC web site is a rich source of information on state and provincial quit lines as

More information

1. To create a comprehensive Benchmark plan that will assure maximum tobacco cessation coverage to all populations in Rhode Island:

1. To create a comprehensive Benchmark plan that will assure maximum tobacco cessation coverage to all populations in Rhode Island: POSTION STATEMENT Submitted to the Rhode Island Health Benefits Exchange Submitted By the Public Policy Workgroup of the Statewide Tobacco Cessation Committee on Tobacco Cessation Treatment Benchmarks

More information

TOBACCO CESSATION WORKS: AN OVERVIEW OF BEST PRACTICES AND STATE EXPERIENCES

TOBACCO CESSATION WORKS: AN OVERVIEW OF BEST PRACTICES AND STATE EXPERIENCES TOBACCO CESSATION WORKS: AN OVERVIEW OF BEST PRACTICES AND STATE EXPERIENCES Despite reductions in smoking prevalence since the first Surgeon General s report on smoking in 1964, approximately 46 million

More information

Pharmacy Handbook. Understanding Your Prescription Benefit

Pharmacy Handbook. Understanding Your Prescription Benefit Pharmacy Handbook Understanding Your Prescription Benefit 1 Welcome to Your Prescription Drug Plan! Health Republic Insurance of New York has partnered with US Script to manage your prescription drug benefits.

More information

Country profile. Bhutan

Country profile. Bhutan WHO Report on the Global Tobacco Epidemic, 2015 Country profile Bhutan WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 09 December 2003 Date of ratification (or legal equivalent)

More information

AVAIL VAPOR RESPONDS TO REQUEST FROM FEDERAL DRUG ADMINISTRATION TO PROVIDE FEEDBACK FROM E-CIGARETTE USERS

AVAIL VAPOR RESPONDS TO REQUEST FROM FEDERAL DRUG ADMINISTRATION TO PROVIDE FEEDBACK FROM E-CIGARETTE USERS AVAIL VAPOR RESPONDS TO REQUEST FROM FEDERAL DRUG ADMINISTRATION TO PROVIDE FEEDBACK FROM E-CIGARETTE USERS Q2 What is your age? Answered: 8,509 Skipped: 18 18-20 21-29 30-39 40-49 50-59 60 or older 18-20

More information

Health Insurance Benefits for Treatment of Tobacco Dependence. Summary

Health Insurance Benefits for Treatment of Tobacco Dependence. Summary S U M M A R Y R E P O R T O F T H E P A C I F I C C E N T E R O N H E A L T H A N D T O B A C C O Health Insurance Benefits for Treatment of Tobacco Dependence Summary $ Why do tobacco users need health

More information

Parisa Vatanka, PharmD Pharmacy Strategic Alliances Manager Assistant Clinical Professor, UCSF. Stan Leung, PharmD Clinical Division Lead

Parisa Vatanka, PharmD Pharmacy Strategic Alliances Manager Assistant Clinical Professor, UCSF. Stan Leung, PharmD Clinical Division Lead Parisa Vatanka, PharmD Pharmacy Strategic Alliances Manager Assistant Clinical Professor, UCSF Stan Leung, PharmD Clinical Division Lead April 13, 2015 ! PrevenFve Care Immuniza(ons (aligned with ACIP

More information

Clinical Trials Network

Clinical Trials Network National Drug Abuse Treatment Clinical Trials Network STOP SMOKING STUDY Should I Join? NATIONAL INSTITUTES OF HEALTH U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Introduction Many people who abuse drugs

More information

WHEREAS updates are required to the Compensation Plan for Pharmacy Services;

WHEREAS updates are required to the Compensation Plan for Pharmacy Services; M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta

More information

Have we got the balance right? Return on investment

Have we got the balance right? Return on investment Have we got the balance right? Return on investment from brain, behavioural and social sciences in the field of addiction Robert West University College London @robertjwest 1 Declaration of interests I

More information

Smoking Cessation in People with Severe Mental Illness. Lisa Dixon, M.D., MPH and Melanie Bennett, Ph.D. University of Maryland School of Medicine

Smoking Cessation in People with Severe Mental Illness. Lisa Dixon, M.D., MPH and Melanie Bennett, Ph.D. University of Maryland School of Medicine Smoking Cessation in People with Severe Mental Illness Lisa Dixon, M.D., MPH and Melanie Bennett, Ph.D. University of Maryland School of Medicine Smoking and Severe Mental Illness Smoking is a MAJOR problem

More information

T obacco use is rising among young adults (aged 18 24

T obacco use is rising among young adults (aged 18 24 ii20 Tobacco use by Massachusetts public college students: long term effect of the Massachusetts Tobacco Control Program N A Rigotti, S Regan, N E Majchrzak, J R Knight, H Wechsler... Tobacco Control 2002;11(Suppl

More information

E-cigarette Briefing for Health & Social Care Professionals

E-cigarette Briefing for Health & Social Care Professionals E-cigarette Briefing for Health & Social Care Professionals 1. The Context 1.1 Smoking is the largest single cause of premature deaths and preventable ill-health in England. In 2011 among adults aged 35

More information

Kylie Morphett. Smokers understandings of nicotine addiction: A qualitative study.

Kylie Morphett. Smokers understandings of nicotine addiction: A qualitative study. Kylie Morphett Smokers understandings of nicotine addiction: A qualitative study. Why smoking? High prevalence Smoking is the largest preventable cause of disease in Australia Tobacco causes many serious

More information

Submission Form: Consultation on the registered nurse scope of practice May 2009

Submission Form: Consultation on the registered nurse scope of practice May 2009 1 Submission Form: Consultation on the registered nurse scope of practice May 2009 How to make a submission This consultation document has been developed to background issues related to the registered

More information

Country profile. Nigeria

Country profile. Nigeria WHO Report on the Global Tobacco Epidemic, 2015 Country profile Nigeria WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 28 June 2004 Date of ratification (or legal equivalent)

More information

PHARMACEUTICAL MANAGEMENT PROCEDURES

PHARMACEUTICAL MANAGEMENT PROCEDURES PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription

More information

National Standard for Tobacco Cessation Support Programme

National Standard for Tobacco Cessation Support Programme National Standard for Tobacco Cessation Support Programme STANDARDS DOCUMENT The development of a National Standard for Intensive Tobacco Cessation Support Services is one of the key priorities of the

More information

Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update Part 2

Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update Part 2 Office of Medical Assistance Programs Electronic Health Record (EHR) Incentive Program Stage 2 Final Rule Update Part 2 November 7, 2012 Medical Assistance HIT Initiative 1 Office of Medical Assistance

More information

NY Medicaid EHR Incentive Program. Eligible Professionals Meaningful Use Stage 2 (MU2) Webinar www.emedny.org/meipass

NY Medicaid EHR Incentive Program. Eligible Professionals Meaningful Use Stage 2 (MU2) Webinar www.emedny.org/meipass Eligible Professionals Meaningful Use Stage 2 (MU2) Webinar www.emedny.org/meipass May 2015 2 Meaningful Use Stage 2 Overview of EHR Introduction to Meaningful Use Meaningful Use Stage 2 Objectives Clinical

More information

No Smoking Policy. No Smoking Policy

No Smoking Policy. No Smoking Policy No Smoking Policy Document Status Version: V2.0 Approved DOCUMENT CHANGE HISTORY Initiated by Date Author HR Version Date Comments (i.e. viewed, or reviewed, amended approved by person or committee) V1.1

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE April 8, 2011 EFFECTIVE DATE April 8, 2011 MEDICAL ASSISTANCE BULLETIN NUMBER 03-11-01, 09-11-02, 14-11-01, 18-11-01 24-11-03, 27-11-02, 31-11-02, 33-11-02 SUBJECT Electronic Prescribing Internet-based

More information

Smoking Cessation Leadership Center at UCSF and Pfizer Medical Education Group. Request for Proposals (RFP) July 2, 2012

Smoking Cessation Leadership Center at UCSF and Pfizer Medical Education Group. Request for Proposals (RFP) July 2, 2012 Smoking Cessation Leadership Center at UCSF and Pfizer Medical Education Group Request for Proposals (RFP) July 2, 2012 I. Background The Smoking Cessation Leadership Center (SCLC) at the University of

More information

Integrating Health & Wellness & Peers in Clubhouse Programs

Integrating Health & Wellness & Peers in Clubhouse Programs Integrating Health & Wellness & Peers in Clubhouse Programs Colleen McKay, M.A., C.A.G.S. Program for Clubhouse Research Systems and Psychosocial Advances Research Center University of Massachusetts Medical

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

1.1 WHAT IS A QUIT LINE?

1.1 WHAT IS A QUIT LINE? 1.Benefits and rationale for establishing quit-line services 1.1 WHAT IS A QUIT LINE? Quit lines provide a variety of tobacco cessation services predominately via telephones. These usually include: initial

More information

A Holistic Approach to Smoking Cessation

A Holistic Approach to Smoking Cessation A Holistic Approach to Smoking Cessation 1 Disclosures David A. Baron, DO, the faculty who developed the content for this presentation, has disclosed that he has no actual or potential conflict of interest

More information

Student Health Service FAQs for the Parent and Family Liaison

Student Health Service FAQs for the Parent and Family Liaison 1 Student Health Service FAQs for the Parent and Family Liaison Do I need to send my son or daughter with our prescription insurance card to the University Pharmacy (located at the Student Health Service)

More information

To provide standardized Supervised Exercise Programs across the province.

To provide standardized Supervised Exercise Programs across the province. TITLE ALBERTA HEALTHY LIVING PROGRAM SUPERVISED EXERCISE PROGRAM DOCUMENT # HCS-67-01 APPROVAL LEVEL Executive Director Primary Health Care SPONSOR Senior Consultant Central Zone, Primary Health Care CATEGORY

More information

Appendix 1. CAHPS Health Plan Survey 5.0H Adult Questionnaire (Commercial)

Appendix 1. CAHPS Health Plan Survey 5.0H Adult Questionnaire (Commercial) Appendix 1 CAHPS Health Plan Survey 5.0H Adult Questionnaire (Commercial) 1-2 Appendix 1 CAHPS 5.0H Adult Questionnaire (Commercial) 1-3 CAHPS 5.0H Adult Questionnaire (Commercial) SURVEY INSTRUCTIONS

More information

NATIONAL FORUM JOURNAL OF COUNSELING AND ADDICTION VOLUME 3, NUMBER 1, 2014. Nicotine Addiction

NATIONAL FORUM JOURNAL OF COUNSELING AND ADDICTION VOLUME 3, NUMBER 1, 2014. Nicotine Addiction VOLUME 3, NUMBER 1, 2014 Nicotine Addiction Iyakinoabasi Mbride, MBA Research Assistant College of Education and Human Services Department of Psychology, Counseling, and Special Education Texas A&M University-Commerce

More information

Better Living with Obstructive Pulmonary Disease A Patient Guide

Better Living with Obstructive Pulmonary Disease A Patient Guide Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health The State of Queensland (Queensland Health) and The Australian Lung Foundation 2012 a Better

More information

Introducing... Active Pharmacy service SM. Innovative new ways to enhance benefits and reduce costs

Introducing... Active Pharmacy service SM. Innovative new ways to enhance benefits and reduce costs Introducing... Active Pharmacy service SM Innovative new ways to enhance benefits and reduce costs Did you know... that healthcare costs in Canada have doubled in the last decade?* Added value and cost

More information

SAMPLE SERVICE LEARNING SYLLABUS

SAMPLE SERVICE LEARNING SYLLABUS OUR LADY OF THE LAKE COLLEGE Respiratory Therapy Program COURSE TITLE AND NUMBER: RESP 2733SL Cardiopulmonary Rehabilitation and Home Care TOTAL CREDIT HOURS: 3 PREREQUISITE COURSE(S): COMPLETION OF RESP

More information

Workplace Solutions. from the American Cancer Society. Strategies for Promoting and Implementing a Smoke-free Workplace

Workplace Solutions. from the American Cancer Society. Strategies for Promoting and Implementing a Smoke-free Workplace Strategies for Promoting and Implementing a Smoke-free Workplace Introduction Businesses are becoming increasingly sensitive to health and safety practices at the workplace that protect employees. Tobacco

More information

June G. Javier, PharmD, BCPS Friday, April 17, 2015

June G. Javier, PharmD, BCPS Friday, April 17, 2015 June G. Javier, PharmD, BCPS Friday, April 17, 2015 June Javier declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program,

More information

Smoking Cessation Program

Smoking Cessation Program Guide to Pharmacist Health Coaching Smoking Cessation Program Smoking is the leading cause of preventable death in Canada and a significant risk factor for many chronic non-communicable diseases including

More information

Ass Professor Frances Kay-Lambkin. NHMRC Research Fellow, National Drug and Alcohol Research Centre UNSW

Ass Professor Frances Kay-Lambkin. NHMRC Research Fellow, National Drug and Alcohol Research Centre UNSW Ass Professor Frances Kay-Lambkin NHMRC Research Fellow, National Drug and Alcohol Research Centre UNSW Frances Kay-Lambkin PhD National Health and Medical Research Council Research Fellow Substance Use

More information

Nicotine Management Policy

Nicotine Management Policy Nicotine Management Policy Information for Service Users and Visitors Children and Families Community Services Mental Health Secure Services Specialist Services Medical Directorate Why are we smokefree?

More information

Menthol cigarettes and smoking cessation behavior Authors: Allison C. Hoffman, FDA CTP; Donna Miceli, DLM Writing Services

Menthol cigarettes and smoking cessation behavior Authors: Allison C. Hoffman, FDA CTP; Donna Miceli, DLM Writing Services Not yet peer-reviewed submitted for publication Menthol cigarettes and smoking cessation behavior Authors: Allison C. Hoffman, FDA CTP; Donna Miceli, DLM Writing Services Abstract Although much is known

More information

Main Section. Overall Aim & Objectives

Main Section. Overall Aim & Objectives Main Section Overall Aim & Objectives The goals for this initiative are as follows: 1) Develop a partnership between two existing successful initiatives: the Million Hearts Initiative at the MedStar Health

More information

Expanding Access through Pharmacy-Based Point-of-Care Testing

Expanding Access through Pharmacy-Based Point-of-Care Testing Expanding Access through Pharmacy-Based Point-of-Care Testing Donald G. Klepser, PhD Associate Professor, Department of Pharmacy Practice University of Nebraska Medical Center Doug Read, Pharm.D. Director,

More information

Country profile. India

Country profile. India WHO Report on the Global Tobacco Epidemic, 2015 Country profile India WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 10 September 2003 Date of ratification (or legal equivalent)

More information

Please DON T correct or give the answers to your class.

Please DON T correct or give the answers to your class. 4 th & 5 th Grade Dear Classroom Teacher, Thank you for inviting the Peer Educators, from the Peers with IMPACT program, to present information about alcohol, tobacco and other drug prevention to your

More information

Developing Pharmacist-Managed Clinics in the Outpatient Setting

Developing Pharmacist-Managed Clinics in the Outpatient Setting Developing Pharmacist-Managed Clinics in the Outpatient Setting Name : R Mohd Khairul Anuar R Ismail Unit : Drug Information Unit Preceptor : Pn Zalina Zahari A Primer for Developing Pharmacist- Managed

More information

County of Sonoma, Smoke-Free Substance Abuse Treatment Facilities Assessment Protocol

County of Sonoma, Smoke-Free Substance Abuse Treatment Facilities Assessment Protocol County of Sonoma, Smoke-Free Substance Abuse Treatment Facilities Assessment Protocol OVERVIEW Substance abuse treatment programs are in the business of helping people to get and stay sober. While smoking

More information

Meaningful Use Stage 2 Administrator Training

Meaningful Use Stage 2 Administrator Training Meaningful Use Stage 2 Administrator Training 1 During the call please mute your line to reduce background noise. 2 Agenda Review of the EHR Incentive Programs for Stage 2 Meaningful Use Measures and Corresponding

More information

Waterpipe tobacco smoking among college students in South Carolina. 13 August 2014 SC TRIG Medical University of South Carolina

Waterpipe tobacco smoking among college students in South Carolina. 13 August 2014 SC TRIG Medical University of South Carolina Waterpipe tobacco smoking among college students in South Carolina 13 August 2014 SC TRIG Medical University of South Carolina Acknowledgments Frederick Kates, MBA PhD Candidate Dept. of Health Services

More information

Maximizing Legacy Data Migration to a New EHR

Maximizing Legacy Data Migration to a New EHR WHITE PAPER Maximizing Legacy Data Migration to a New EHR By Joy Ales, MHA, BSN, RN, Sr. Consultant, An Encore Point of View August 2015 Encore, A Quintiles Company AN ENCORE POINT OF VIEW When organizations

More information